Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00365508 · ClinicalTrials.gov registry record · Phase 4
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
A Phase 4 study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 642
- Enrollment target
NCT00365508 is a Phase 4 study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 642 participants.
The verdict
NCT00365508, a Phase 4 study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 642 participants
- Enrollment target
Study Summary
RATIONALE: Stop-smoking plans, including counseling and nicotine replacement therapy, may help smokers quit smoking. It is not yet known whether counseling and the nicotine lozenge is more effective than counseling and the nicotine patch in helping adult smokers quit smoking. PURPOSE: This randomized phase III trial is studying counseling and the nicotine lozenge to see how well they work compared to counseling and the nicotine patch in helping smokers quit smoking.
Interventions
- DRUG nicotine patch
- DRUG nicotine lozenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 642 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00365508
The ClinicalTrials.gov registry entry for NCT00365508 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 642 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which nicotine patch is the first listed.
NCT00365508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00365508 about?
NCT00365508 is a clinical study titled "Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking". RATIONALE: Stop-smoking plans, including counseling and nicotine replacement therapy, may help smokers quit smoking. It is not yet known whether counseling and the nicotine lozenge is more effective than counseling and the nicotine patch in helping adult smokers quit smoking. PURPOSE: This randomiz...
What is the current status of trial NCT00365508?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 642 participants. The study started on 2006-02. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00365508?
The interventions under investigation include: nicotine patch (DRUG), nicotine lozenge (DRUG).
Who is sponsoring clinical trial NCT00365508?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.